Literature DB >> 35821924

Does Isolated Unilateral Hip or Knee Osteoarthritis Lead to Adverse Changes in Extremity Composition?

David E DeMik1, Michael C Marinier1, Trevor R Gulbrandsen1, Natalie A Glass1, Jacob M Elkins1.   

Abstract

Background: While muscle atrophy is a function of normal aging, loss of muscle in the setting of hip and knee osteoarthritis (OA) has been observed using radiographic studies. There is limited data available regarding changes in extremity composition using bioimpedance (BIA). The purpose of this study was to assess the changes in extremity composition in patients with isolated, unilateral hip or knee OA using BIA.
Methods: Patients presenting to our institution's adult reconstruction clinic from February 2020 to April 2021 were retrospectively reviewed to identify those with isolated, unilateral hip and knee OA. The InBody 770 Body Composition Analyzer (InBody USA, Cerritos, California) was used to perform a complete body composition assessment, per protocol. Lean extremity mass (LEM), fat mass (FM), intracellular water (ICW), extremity body water (EBW = ICW + extracellular water (ECW)) and phase angle (PA) were determined. Differences between the affected (OA) and unaffected (no OA) extremities were compared using t-tests.
Results: 38 patients had isolated hip OA. The mean age was 60.8 (±11.7) years, mean BMI was 31.7 (±6.8) kg/m2, and 39.5% were female. LEM, FM, EBW, ICW, and PA were significantly decreased in the hip OA extremity (LEM: 20.0 vs. 20.4 kg, p=0.0008, FM: 8.8 vs. 8.9 kg, p=0.0049, EBW: 15.7 vs 16.0, p=0.0011, ICW: 9.5 vs. 9.7 L, p=0.0004, PA: 4.5 vs 4.9º, p<0.0001). There were 25 patients with isolated knee OA. Mean age was 62.8 (±11.3) years, mean BMI was 33.6 (±6.9) kg/m2, and 52.0% were female. FM and PA were significantly lower in the knee OA extremity (11.3 vs 11.4 kg, p=0.0291, 4.5 vs 4.9º, p<0.0001). There were no significant differences in LEM, EBW, and ICW between the knee OA extremity and the unaffected extremity.
Conclusion: Patients with isolated, unilateral hip OA had decreased LEM, FM, EBW, and ICW in the affected extremity. Both unilateral hip and knee OA was associated with decreased PA, suggestive of greater underlying dysfunction in muscle or cellular performance. Further study is needed to better define when these abnormalities develop, how they progress over time, and the impact of targeted interventions in reversing these changes. Level of Evidence: III.
Copyright © The Iowa Orthopaedic Journal 2022.

Entities:  

Keywords:  body composition; hip; knee; osteoarthritis; phase angle

Mesh:

Substances:

Year:  2022        PMID: 35821924      PMCID: PMC9210432     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  33 in total

1.  Hip abductor muscle volume in hip osteoarthritis and matched controls.

Authors:  A Zacharias; T Pizzari; D J English; T Kapakoulakis; R A Green
Journal:  Osteoarthritis Cartilage       Date:  2016-05-07       Impact factor: 6.576

2.  Avoidance of activity and limitations in activities in patients with osteoarthritis of the hip or knee: a 5 year follow-up study on the mediating role of reduced muscle strength.

Authors:  M F Pisters; C Veenhof; G M van Dijk; J Dekker
Journal:  Osteoarthritis Cartilage       Date:  2013-12-12       Impact factor: 6.576

3.  Alterations in quadriceps muscle cellular and molecular properties in adults with moderate knee osteoarthritis.

Authors:  B Noehren; K Kosmac; R G Walton; K A Murach; M F Lyles; R F Loeser; C A Peterson; S P Messier
Journal:  Osteoarthritis Cartilage       Date:  2018-05-23       Impact factor: 6.576

Review 4.  A critical review of weight loss recommendations before total knee arthroplasty.

Authors:  Kristine Godziuk; Carla M Prado; Lauren Beaupre; C Allyson Jones; Jason R Werle; Mary Forhan
Journal:  Joint Bone Spine       Date:  2020-12-02       Impact factor: 4.929

5.  What are the implications of withholding total joint arthroplasty in the morbidly obese? A prospective, observational study.

Authors:  B D Springer; K M Roberts; K L Bossi; S M Odum; D C Voellinger
Journal:  Bone Joint J       Date:  2019-07       Impact factor: 5.082

6.  Impact of phase angle on postoperative prognosis in patients with gastrointestinal and hepatobiliary-pancreatic cancer.

Authors:  Sonoko Yasui-Yamada; Yu Oiwa; Yu Saito; Nozomi Aotani; Atsumi Matsubara; Sayaka Matsuura; Mayu Tanimura; Yoshiko Tani-Suzuki; Hideya Kashihara; Masaaki Nishi; Mitsuo Shimada; Yasuhiro Hamada
Journal:  Nutrition       Date:  2020-06-06       Impact factor: 4.008

7.  The associations of phase angle with the structural severity and quadriceps strength among patients with hip osteoarthritis: the SPSS-OK study.

Authors:  Osamu Wada; Minoru Yamada; Tsukasa Kamitani; Kiyonori Mizuno; Noriaki Kurita
Journal:  Clin Rheumatol       Date:  2020-09-29       Impact factor: 2.980

8.  Evaluation of multi-frequency bioelectrical impedance analysis for the assessment of body composition in individuals with obesity.

Authors:  P A Sullivan; C D Still; S T Jamieson; C B Dixon; B A Irving; J L Andreacci
Journal:  Obes Sci Pract       Date:  2018-12-26

Review 9.  Effect of non-surgical, non-pharmacological weight loss interventions in patients who are obese prior to hip and knee arthroplasty surgery: a rapid review.

Authors:  Michelle Lui; C Allyson Jones; Marie D Westby
Journal:  Syst Rev       Date:  2015-09-27

10.  Pitfalls in the measurement of muscle mass: a need for a reference standard.

Authors:  Fanny Buckinx; Francesco Landi; Matteo Cesari; Roger A Fielding; Marjolein Visser; Klaus Engelke; Stefania Maggi; Elaine Dennison; Nasser M Al-Daghri; Sophie Allepaerts; Jurgen Bauer; Ivan Bautmans; Maria Luisa Brandi; Olivier Bruyère; Tommy Cederholm; Francesca Cerreta; Antonio Cherubini; Cyrus Cooper; Alphonso Cruz-Jentoft; Eugene McCloskey; Bess Dawson-Hughes; Jean-Marc Kaufman; Andrea Laslop; Jean Petermans; Jean-Yves Reginster; René Rizzoli; Sian Robinson; Yves Rolland; Ricardo Rueda; Bruno Vellas; John A Kanis
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-01-19       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.